Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA

被引:69
作者
Chan, JYW [1 ]
Chu, ACY [1 ]
Fung, KP [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China
关键词
antisense nucleic acid; multiple drug resistance; P-glycoprotein;
D O I
10.1016/S0024-3205(00)00798-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein, In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR), To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot, By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells, The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced. (C) 2000 Elsevier Science Inc, All rights reserved.
引用
收藏
页码:2117 / 2124
页数:8
相关论文
共 20 条
[11]   MECHANISM OF ACTION OF ANTISENSE RNA - SOMETIME INHIBITION OF TRANSCRIPTION, PROCESSING, TRANSPORT, OR TRANSLATION [J].
DENHARDT, DT .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 660 :70-76
[12]   Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy [J].
Fakhrai, H ;
Dorigo, O ;
Shawler, DL ;
Lin, H ;
Mercola, D ;
Black, KL ;
Royston, I ;
Sobol, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :2909-2914
[13]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[14]  
GERLACH JH, 1986, CANCER SURV, V5, P25
[15]   Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides [J].
Hatta, T ;
Nakagawa, Y ;
Takai, K ;
Nakada, S ;
Yokota, T ;
Takaku, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 223 (02) :341-346
[16]  
KIMURA S, 1995, CANCER RES, V55, P1379
[17]   Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 induction [J].
Li, X ;
Smyth, AP ;
Barrett, DJ ;
Ivy, SP ;
vonHofe, E .
LEUKEMIA, 1997, 11 (07) :950-957
[18]  
MANFRED V, 1998, ANTICANCER RES, V18, P2905
[19]   Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides [J].
Motomura, S ;
Motoji, T ;
Takanashi, M ;
Wang, YH ;
Shiozaki, H ;
Sugawara, I ;
Aikawa, E ;
Tomida, A ;
Tsuruo, T ;
Kanda, N ;
Mizoguchi, H .
BLOOD, 1998, 91 (09) :3163-3171
[20]  
TSURUO T, 1983, CANCER RES, V43, P2905